Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus-2 Omicron Variant of Concern

被引:31
|
作者
Saxena, Shailendra K. [1 ,2 ,3 ]
Kumar, Swatantra [1 ,2 ]
Ansari, Saniya [1 ,2 ]
Paweska, Janusz T. [2 ,4 ]
Maurya, Vimal K. [1 ,2 ]
Tripathi, Anil K. [1 ]
Abdel-Moneim, Ahmed S. [5 ]
机构
[1] King Georges Med Univ KGMU, Fac Med, Ctr Adv Res CFAR, Lucknow 226003, Uttar Pradesh, India
[2] World Soc Virol WSV, Al Taif, Saudi Arabia
[3] Indian Virol Soc IVS, New Delhi, India
[4] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Emerging Zoonot & Parasit Dis, PB 104, Johannesburg, South Africa
[5] Taif Univ, Coll Med, Dept Microbiol, Al Taif, Saudi Arabia
关键词
COVID-19; Delta; Omicron; B; 1; 529; receptor-binding domain; SARS-CoV-2; Variants of Concern; DISEASE;
D O I
10.1002/jmv.27611
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The novel Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variant, Omicron (PANGO lineage B.1.1.529) is being reported from all around the world. The WHO has categorized Omicron as a Variant of Concern (VOC) considering its higher transmissibility and infectivity, vaccine breakthrough cases. As of January 6, 2022, Omicron has been reported in at least 149 countries. Therefore, this study was planned to investigate the transmission dynamics and mutational prevalence of the novel SARS-CoV-2 Omicron variant. The transmission dynamics and Omicron SARS-CoV-2 divergence was studied using GISAID and Nextstrain which provides information about the genetic sequences, epidemiological, geographical, and species-specific data of human, avian, and animal viruses. Further, the mutation prevalence in spike glycoprotein of Omicron was studied, and the frequency of the crucial mutations was compared with the other prevalent VOCs. The transmission dynamics suggest that the Omicron was first identified in South Africa and then it was reported in the United Kingdom followed by the United States and Australia. Further, our phylogenetic analysis suggests that Omicron (BA.1) was clustered distinctly from the other VOCs. In the Spike glycoprotein, the Omicron (B.1.1.529) demonstrates critical 32 amino acid changes. This study may help us to understand mutational hotspots, transmission dynamics, phylogenetic divergence, effect on testing and immunity, which shall promote the progress of the clinical application and basic research.
引用
收藏
页码:2160 / 2166
页数:7
相关论文
共 50 条
  • [1] An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
    Paz, Mercedes
    Aldunate, Fabian
    Arce, Rodrigo
    Ferreiro, Irene
    Cristina, Juan
    VIRUS RESEARCH, 2022, 314
  • [2] Smell and taste dysfunction in patients infected with the Omicron variant of severe acute respiratory syndrome coronavirus-2
    Chen, Yanping
    Geng, Yan
    Jiang, Juan
    Xiong, Gaoyun
    Lei, Chenyang
    ACTA OTO-LARYNGOLOGICA, 2023, 143 (06) : 489 - 494
  • [3] Prevalence of severe acute respiratory syndrome Coronavirus-2 among the young people and association between diabetes, hypertension, and severe acute respiratory syndrome Coronavirus-2
    Akter, Aklima
    Tabassum, Nafisa
    Rahman, Arifur
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2021, 5 (02): : 134 - 138
  • [4] Omicron, a New Variant of Severe Acute Respiratory Syndrome Coronavirus-2 Virus: Global Upsurge, Devastation, and Future Prospect
    Kumar, Awanish
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2022, 6 (04): : 594 - 597
  • [5] Household Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 in the United States
    Lewis, Nathaniel M.
    Chu, Victoria T.
    Ye, Dongni
    Conners, Erin E.
    Gharpure, Radhika
    Laws, Rebecca L.
    Reses, Hannah E.
    Freeman, Brandi D.
    Fajans, Mark
    Rabold, Elizabeth M.
    Dawson, Patrick
    Buono, Sean
    Yin, Sherry
    Owusu, Daniel
    Wadhwa, Ashutosh
    Pomeroy, Mary
    Yousaf, Anna
    Pevzner, Eric
    Njuguna, Henry
    Battey, Katherine A.
    Tran, Cuc H.
    Fields, Victoria L.
    Salvatore, Phillip
    O'Hegarty, Michelle
    Vuong, Jeni
    Chancey, Rebecca
    Gregory, Christopher
    Banks, Michelle
    Rispens, Jared R.
    Dietrich, Elizabeth
    Marcenac, Perrine
    Matanock, Almea M.
    Duca, Lindsey
    Binder, Allison
    Fox, Garrett
    Lester, Sandra
    Mills, Lisa
    Gerber, Susan, I
    Watson, John
    Schumacher, Amy
    Pawloski, Lucia
    Thornburg, Natalie J.
    Hall, Aron J.
    Kiphibane, Tair
    Willardson, Sarah
    Christensen, Kim
    Page, Lindsey
    Bhattacharyya, Sanjib
    Dasu, Trivikram
    Christiansen, Ann
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E1805 - E1813
  • [6] Severe Acute Respiratory Syndrome Coronavirus-2 Delta Variant Study In Vitro and Vivo
    Avagyan, Hranush
    Hakobyan, Sona
    Poghosyan, Arpine
    Hakobyan, Lina
    Abroyan, Liana
    Karalova, Elena
    Avetisyan, Aida
    Sargsyan, Mariam
    Baghdasaryan, Bagrat
    Bayramyan, Nane
    Avetyan, Diana
    Karalyan, Zaven
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (01) : 249 - 267
  • [8] A Case of Acute Pancreatitis Associated With the Novel Severe Acute Respiratory Syndrome Coronavirus-2
    Samad, Sara
    St Cyr, Nikolas
    Basit, Abdul
    Sinha, Neera
    Abdullah, Muhammad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S807 - S808
  • [9] Rapid Emergence of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Korea
    Park, Ae Kyung
    Kim, Il-Hwan
    Lee, Chae Young
    Kim, Jeong-Ah
    Lee, Hyeokjin
    Kim, Heui Man
    Lee, Nam-Joo
    Woo, SangHee
    Lee, Jaehee
    Rhee, JeeEun
    Yoo, Cheon-Kwon
    Kim, Eun-Jin
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (02) : 211 - 213
  • [10] Seizure in children with severe acute respiratory syndrome coronavirus 2 Omicron variant infection
    Iio, Kazuki
    Hagiwara, Yusuke
    Saito, Osamu
    Ishida, Yu
    Horikoshi, Yuho
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)